Back to Journals » International Journal of General Medicine » Volume 6
Hydrogen potassium adenosine triphosphatase activity inhibition and downregulation of its expression by bioactive fraction DLBS2411 from Cinnamomum burmannii in gastric parietal cells
Authors Tjandrawinata RR , Nailufar F , Arifin PF
Received 18 June 2013
Accepted for publication 23 July 2013
Published 23 September 2013 Volume 2013:6 Pages 807—815
DOI https://doi.org/10.2147/IJGM.S50134
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Raymond R Tjandrawinata1,2, Florensia Nailufar2, Poppy F Arifin1
1Section of Molecular Pharmacology, 2Section of Animal Pharmacology, Dexa Medica, Cikarang, Indonesia
Abstract: This study assessed the gastric acid antisecretory effect of DLBS2411 fractionated from Cinnamomum burmannii. Hydrogen potassium adenosine triphosphatase (H+/K+ ATPase) activity and its gene expression were observed, and the antioxidant activity of DLBS2411 was also investigated. Treatment of DLBS2411 decreased the level of H+/K+ ATPase messenger RNA expression on human embryonic kidney 293 cells and rat gastric parietal cells in a dose-dependent manner, in vitro and ex vivo. DLBS2411 also acted as a competitive inhibitor by showing inhibition in gastric H+/K+ ATPase activity at various pHs. In gastric ulcer animal models induced with indomethacin and ethanol, DLBS2411showed a reduction in the number of petechiae, suggesting that the fraction also confers gastroprotective activity. Moreover, DLBS2411 was also found to have potent antioxidant activity. Taken together, DLBS2411 is a promising novel agent for the management of dyspepsia, a condition of hyperacidity and diseases in the stomach requiring gastroprotection.
Keywords: H+/K+ ATPase, proton-pump inhibitor, proton-pump downregulator, gastroprotective
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.